Management of Raynaud’s Phenomenon

John D. Pauling

Molluscum Update (January 2024)

Elaine C. Siegfried

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Practical Practice Pearls

Stephen Stone

Deroofing in HS

Hidradenitis Suppurativa Foundation

S. Daveluy

Management of Necrotizing Fasciitis

Michael Booth

M. Booth

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Skin Signs of Systemic Disease: Addressing Non-Responders and Caring…

Dermatology Education Foundation (DEF)

B. Glick

Hidradenitis Suppurativa: Starting Treatments

Hidradenitis Suppurativa Foundation

S. Daveluy

Dermatologic Toxicities to Immunotherapy

University of Louisville

A. Markova

Myths and Misconceptions ANCA Associated Vasculitis

RheumNow

M. Putman

Bullous Pemphigoid Updates (2024)

NYU Langone

P. Adotama

Rheumatology Update for the Generalist in 2024

McMaster University Department of Medicine

R. Mirza

AAD 2024 Insights: Efficiently Managing HS in Any Clinic

Hidradenitis Suppurativa Foundation

S. Daveluy

AAD 2024 Insights: Practical Practice Pearls

AAD 2024

S. Stone

Cleveland Clinic Rheumatic Case Studies: 32 y/o Male w/ Inflammatory…

Cleveland Clinic Rheumatology

L. Calabrese, J. Gelfand, C. Oddis, J. Cush, A. Kavanaugh, R. Hajj-Ali

How Does the Treatment of Behçet’s Disease Differ Based on Disease M…

Cleveland Clinic Rheumatology

G. Hatemi

Panel Discussion on Hair, Scalp & Nail Dermatologic Conditions: How …

LivDerm

L. Stein Gold, A. W. Armstrong, D. J. Goldberg, A. Mcmichael

What’s Causing the Inflammatory Arthritis & Weight Loss? Why Did a R…

Cleveland Clinic Rheumatology Case Studies

A. Brown

70 y/o Male With Seropositive RA, ANCA Vasculitis, and ILD: Would An…

Keck School of Medicine of USC

C. Chen